A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer
Status:
Recruiting
Trial end date:
2024-10-06
Target enrollment:
Participant gender:
Summary
The purpose of the study is to see if the combination of radiation therapy and cemiplimab
immunotherapy is an effective treatment for people with locally advanced, unresectable CSCC.